The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Second-line prescribing preferences of U.S. hematology-oncology physicians for patients (pts) with recurrent multiple myeloma (MM): Impact of novel agents.
 
Robert Z. Orlowski
Honoraria - Celgene
Consulting or Advisory Role - Amgen; Array BioPharma; Bristol-Myers Squibb; Celgene; FORMA Therapeutics; Incyte
Research Funding - Amgen; Array BioPharma; Bristol-Myers Squibb; Celgene
 
Joanne P. Willey
No Relationships to Disclose
 
Maria L. Lankford
No Relationships to Disclose
 
Arden Buettner
No Relationships to Disclose
 
Stewart Kaufman
No Relationships to Disclose
 
Susan Lynne Britton
No Relationships to Disclose
 
Mitchell Scharf
No Relationships to Disclose
 
Brynn Tiscione
No Relationships to Disclose
 
Doug B. Neely
No Relationships to Disclose
 
Joel H. Schwartz
Honoraria - Amgen; Celgene; Takeda